Wave Life Sciences (WVE) Equity Average (2016 - 2025)
Historic Equity Average for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $131.9 million.
- Wave Life Sciences' Equity Average rose 9094.48% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.9 million, marking a year-over-year increase of 9094.48%. This contributed to the annual value of $124.6 million for FY2024, which is 466225.97% up from last year.
- As of Q3 2025, Wave Life Sciences' Equity Average stood at $131.9 million, which was up 9094.48% from $155.5 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Equity Average registered a high of $190.7 million during Q1 2025, and its lowest value of -$46.1 million during Q3 2023.
- For the 5-year period, Wave Life Sciences' Equity Average averaged around $43.1 million, with its median value being $25.9 million (2021).
- In the last 5 years, Wave Life Sciences' Equity Average crashed by 44889.51% in 2023 and then skyrocketed by 4112278.04% in 2024.
- Wave Life Sciences' Equity Average (Quarter) stood at $31.2 million in 2021, then crashed by 179.5% to -$24.8 million in 2022, then soared by 98.27% to -$428000.0 in 2023, then soared by 41122.78% to $175.6 million in 2024, then dropped by 24.87% to $131.9 million in 2025.
- Its Equity Average stands at $131.9 million for Q3 2025, versus $155.5 million for Q2 2025 and $190.7 million for Q1 2025.